SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-24-001273
Filing Date
2024-04-09
Accepted
2024-04-09 10:26:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13-G/A zk2431267.htm SC 13G/A 66920
  Complete submission text file 0001178913-24-001273.txt   68567
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-55457 | Film No.: 24831486
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 53 DERECH HA'SHALOM ST. GIVATAYIM L3 53454
Business Address 53 DERECH HA'SHALOM ST. GIVATAYIM L3 53454 972-3-733-2997
Phoenix Holdings Ltd. (Filed by) CIK: 0001679543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A